综述

纽约食管鳞状细胞癌1的研究进展

  • 杨海瑞 徐帆洪
展开
  • 上海生物制品研究所有限责任公司第一研究室  200051

网络出版日期: 2025-08-16

Progress in research of New York esophageal squamous cell carcinoma 1

Expand
  • No. 1 Research Laboratory, Shanghai Institute of Biological Products Co., Ltd., Shanghai 200051, China

Online published: 2025-08-16

摘要

 纽约食管鳞状细胞癌1(New York esophageal squamous cell carcinoma 1,NY-ESO-1)是一种癌-睾丸抗原。其表达于多种肿瘤,但在正常组织中极少表达,且具有可同时诱导体液和细胞免疫应答的强免疫原性,因此被认为是一种肿瘤免疫治疗的理想抗原。此文概述了对NY-ESO-1与肿瘤的相关研究以及基于NY-ESO-1的免疫治疗的研究进展。

本文引用格式

杨海瑞 徐帆洪 . 纽约食管鳞状细胞癌1的研究进展[J]. 国际生物制品学杂志, 2019 , 42(6) : 304 -308 . DOI: 10.3760/cma.j.issn.1673-4211.2019.06.010

Abstract

 New York esophageal squamous cell carcinoma 1(NY-ESO-1) is a member of cancer-testis antigens. NY-ESO-1’s characteristic expression in multiple types of human cancers but rare presence in normal tissues, together with its ability to simulataneously elicit humoral and cellular immune responses, have rendered it a good candidate target for cancer immunotherapy. This paper reviews the studies of NY-ESO-1 association with cancers and the research progresses of NY-ESO-1 targeted immunotherapeutic strategies.
文章导航

/